Details for Patent: 6,626,870
✉ Email this page to a colleague
Summary for Patent: 6,626,870
Title: | Stoppering method to maintain sterility |
Abstract: | A syringe assembly is provided which includes a hollow barrel that has an interior wall. The interior wall defines a chamber that retains medication. The hollow barrel also includes a distal end and a proximal end. The distal end of the hollow barrel has a passageway that is in contact with the chamber. The proximal end of the hollow barrel has an aperture. The syringe assembly also includes a primary plunger tip that is slidably positioned, in fluid tight engagement, with the interior wall. The primary plunger tip has a receptor to engage an engager of an elongated tip plunger rod. The syringe assembly also includes a secondary plunger tip that is slidably positioned, in fluid tight engagement, with the interior wall. The secondary plunger tip also has a receptor to engage an engager of a tip plunger rod. The secondary plunger tip is disposed between the primary plunger tip and the proximal end of the hollow barrel. The syringe assembly also includes a tip plunger rod, which facilitates operation of the secondary plunger tip, engaged to the secondary plunger tip. The present invention also provides a process for providing a lyophilized medication (i.e., lyophilizate) in a syringe assembly and also provides a process for reconstituting a medication in a syringe assembly. |
Inventor(s): | Yarborough; Cody L (Ft. Collins, CO), Duncan; Michael R. (Ft. Collins, CO), Norton; Richard L. (Ft. Collins, CO), Bawa; Rajan (Ft. Collins, CO), Madril; Dominic G. (Loveland, CO), Barrett; Christopher J. (Ft. Collins, CO) |
Assignee: | Artix Laboratories, Inc. (Fort Collins, CO) |
Application Number: | 09/536,479 |
Patent Claim Types: see list of patent claims | Process; |
Drugs Protected by US Patent 6,626,870
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,626,870
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 285261 | ⤷ Try a Trial | |||
Australia | 2001249497 | ⤷ Try a Trial | |||
Australia | 4949701 | ⤷ Try a Trial | |||
Canada | 2404194 | ⤷ Try a Trial | |||
Germany | 60107935 | ⤷ Try a Trial | |||
Denmark | 1267965 | ⤷ Try a Trial | |||
European Patent Office | 1267965 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |